PATENT CLAIM ANALYSIS

Application Number: 15997451
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "183000"]

Abstract:
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein are pharmaceutical composition containing them and methods of using the conjugates and compositions. Also described are processes for manufacture of the conjugates and the compositions containing them.

Claim (Index 31):
The conjugate of  claim 30  wherein D further comprises a radioactive isotope of a metal coordinated to the chelating group.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 94.0
- Lexical Diversity: 1.55556
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15990095', '15990111', '15990136', '15990083', '15990144']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8368981859585427
- 35 USC 102 Novelty (BERT): 0.6033232651200179
- Combined Prediction Score: 0.8135406938746903
- Mean Citation Score: 607.6527640000003
- Max Citation Score: 613.7715
- Similarity Product: 451.1456211392283

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test